Host: Larry Kaskel, MD
Guest: Eliot Brinton
The Women's Health Initiative trial reported that hormone replacement therapy increases the risks of coronary artery disease in postmenopausal women. Dr. Eliot Brinton, director of the metabolism section of the cardiovascular genetics department at the University of Utah School of Medicine in Salt Lake City, and a founding board member of the National Lipid Association and the American Board of Clinical Lipidology, discusses with host Dr. Larry Kaskel a new analysis of the Women's Health Initiative that disputes these findings. Dr. Brinton explores the various risks associated with estrogen, provides guidance on how to evaluate the use of estrogen in postmenopausal women, as well as the practice of stopping estrogen. Tune in to hear Dr. Brinton identify the evidence that supports the cardio-protective effects of estrogen as well the relationship between stroke and estrogen use.
Brought to you by:
